|
CNTA | Centessa Pharmaceuticals Plc |
|
|
CNTA | Centessa Pharmaceuticals Plc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.19 |
| Leverage | 28.05% |
| Market Cap | $ 1.5B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -156.1m |
| Margin | 2171.23% |
Centessa Pharmaceuticals Limited, a pharmaceutical company, develops and delivers drugs that change and improve the lives of patients. The company is headquartered in Cambridge, the United Kingdom.